Fundraising FoxImel BioTherapeutics
Waltham, US · Founded 2019 · 2 known investors
Find your way into Imel BioTherapeutics
Sign up to see every warm intro you have to Imel BioTherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Imel BioTherapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
DP
Dori PelledExecutive
Board
TI
TK
SN
Silvia Noiman, Ph.D.Board director
Investors · 2
Reported raises · per SEC filings
Form D private placements$15M disclosed across 1 round · 2021
▶$15MraisedNov 2021 · 5 investors · Other Health CareRule 506(b)
▶$15MraisedNov 2021 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Taro InabaDirector
- Tomer KarivDirector
- Dori PelledExecutive Officer
- Silvia Noiman, Ph.D.Executive Officer, Director
- Offering amount
- $20M
- Amount sold
- $15M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Imel BioTherapeutics's investors?
- Imel BioTherapeutics's investors include Pontifax Venture Capital, Remiges Ventures, Inc..
- How much funding has Imel BioTherapeutics raised?
- Imel BioTherapeutics has disclosed $15M raised across 1 round.
- Where is Imel BioTherapeutics headquartered?
- Imel BioTherapeutics is headquartered in Waltham, US.